Skip to main content

Decoy Therapeutics Inc.

DCOY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001615219

No open-market purchases or sales by Decoy Therapeutics Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $31.0K in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Decoy Therapeutics Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
+4 vs. Q3 2025
Shares held
79.3K
+78.7K (+14,657.9%) vs. Q3 2025
Total value
$51.4K
+$49.5K (+2,501.4%) vs. Q3 2025
New holders
5
2 more added
Sold out
1
0 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DCOY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 9 institutions
Q1 2021: 34 institutionsQ2 2021: 34 institutionsQ3 2021: 27 institutionsQ4 2021: 28 institutionsQ1 2022: 28 institutionsQ2 2022: 27 institutionsQ3 2022: 22 institutionsQ4 2022: 9 institutionsQ1 2023: 11 institutionsQ2 2023: 14 institutionsQ3 2023: 14 institutionsQ4 2023: 16 institutionsQ1 2024: 13 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 5 institutionsQ4 2025: 9 institutionsQ1 2026: 4 institutionsQ2 2026: 4 institutions
Value heldQ4 2025: $51.4K
Q1 2021: $22.8MQ2 2021: $10.7MQ3 2021: $6.84MQ4 2021: $2.63MQ1 2022: $1.45MQ2 2022: $859.0KQ3 2022: $671.0KQ4 2022: $110.9KQ1 2023: $186.0KQ2 2023: $321.5KQ3 2023: $226.8KQ4 2023: $169.8KQ1 2024: $101.9KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $1.98KQ4 2025: $51.4KQ1 2026: $10.5KQ2 2026: $31.0K
Institutions holding DCOY and their total value by quarter
QuarterHoldersValue
Q2 20264$31.0K
Q1 20264$10.5K
Q4 20259$51.4K
Q3 20255$1.98K
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 202413$101.9K
Q4 202316$169.8K
Q3 202314$226.8K
Q2 202314$321.5K
Q1 202311$186.0K
Q4 20229$110.9K
Q3 202222$671.0K
Q2 202227$859.0K
Q1 202228$1.45M
Q4 202128$2.63M
Q3 202127$6.84M
Q2 202134$10.7M
Q1 202134$22.8M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Decoy Therapeutics Inc.; share changes are against Q3 2025.

Institutions holding DCOY in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Warberg Asset Management LLC28,000$18.2K0.01%+28,000New
StoneX Group Inc.19,992$13.0K0.00%+19,992New
XTX Topco Ltd10,941$7.10K0.00%+10,941New
Geode Capital Management, LLC10,922$7.08K0.00%+10,922New
UBS Group AG4,918$3.19K0.00%+4,889+16,858.6%Added
Tower Research Capital LLC (TRC)4,437$2.88K0.00%+4,437New
Bank of America Corp36$230.00%+32+800.0%Added
Advisor Group Holdings, Inc.3$10.00%00.0%Unchanged
Danske Bank A/S1$10.00%00.0%Unchanged
Advisory Services Network, LLC0$00.00%−500−100.0%Sold out